# Plasma proteomic signatures of cellular aging predict human disease.

- **DOI:** [10.1038/s41591-026-04446-y](https://doi.org/10.1038/s41591-026-04446-y)
- **Rating:** Sound (3.0 out of 5)
- **Verdict:** Large-scale plasma proteomics links putative cell-specific aging signatures to disease and mortality, but missing prognostic baselines limits predictive interpretation.
- **Framework version:** v5.9
- **Pipeline version:** v0.4
- **Evaluation date:** 2026-10-08
- **Evaluation page:** https://www.nabu.science/paper/10.1038%2Fs41591-026-04446-y

## Key claims

1. Cellular aging signatures were associated with disease status and predicted incident disease and mortality over 15 years of follow-up.
   - Support: Tentative
   - Type: Primary finding
   - Basis: hazard associations support stratification, but predictive discrimination, calibration and incremental value were not reported
   - Location: Abstract
2. Individuals with extremely aged compared to youthful skeletal myocytes exhibited a 12.7-fold higher risk of developing amyotrophic lateral sclerosis.
   - Support: Tentative
   - Type: Secondary
   - Basis: the reported association uses a small youthful reference group with uncertain event counts and estimate stability
   - Location: Abstract; Results, incident ALS; Fig. 3c
3. Extreme astrocyte aging tripled the risk of incident Alzheimer's Disease in individuals with two APOE4 alleles, while youthful astrocytes reduced risk.
   - Support: Supported
   - Type: Secondary
   - Basis: cumulative incidence supports the threefold contrast, though the youthful APOE4/4 group contained only 23 participants
   - Location: Abstract; Results, APOE-stratified AD analysis; Fig. 3e
4. In individuals who smoked, extreme respiratory epithelial cell aging was associated with a 58% higher lung cancer risk compared to smoking alone.
   - Support: Supported
   - Type: Secondary
   - Basis: the reported hazards support the contrast, with observational adjustment rather than clinical prediction testing
   - Location: Abstract; Results, lung cancer; Fig. 4a
5. We developed a polycellular aging risk score that stratified mortality risk across cohorts and proteomics platforms.
   - Support: Tentative
   - Type: Secondary
   - Basis: one external cohort and cohort-specific percentile thresholds support stratification but not platform-agnostic deployment
   - Location: Abstract; Results, PARS; Fig. 5e–f

## Strengths

- **Large multi-cohort longitudinal evidence base** The analysis covers 60,542 individuals across GNPC, UKB and NSHD, with prospective disease and mortality follow-up in UKB and repeated measurements in NSHD.
  - Dimension: contribution
  - Location: Main, study overview; Results; Figs. 1, 3–5
- **Held-out and cross-platform evaluation** Olink clocks and PARS were developed in the UKB training partition and evaluated in a held-out test partition, while PARS was also applied to SomaScan measurements in NSHD.
  - Dimension: methodological rigour
  - Location: Methods, Cellular Age Estimation and PARS Development; Fig. 5e–f
- **Targeted adjustments and sensitivity analyses** The study benchmarks astrocyte aging against APOE4, PRS and age, adjusts respiratory signatures for smoking exposure, and repeats the ALS analysis after a three-year diagnostic lag.
  - Dimension: methodological rigour
  - Location: Fig. 3f; Extended Data Figs. 6 and 9; Methods, Prognostic Analysis

## Limitations

- **Prediction lacks essential performance benchmarks** The disease and mortality analyses emphasize hazard ratios and survival separation without reporting discrimination, calibration or broad comparisons against established clinical and general proteomic prognostic models.
  - Dimension: methodological rigour
  - Location: Results, Figs. 3–5; Methods, Prognostic Analysis and PARS Development
- **Cell specificity remains unisolated** The analysis does not compare the assigned panels with matched random protein sets, whole-proteome models or organ clocks, so the endpoint value attributable to cell-type mapping is unresolved.
  - Dimension: methodological rigour
  - Location: Methods, Identification of Cell Type-Enriched Plasma Proteins and Cellular Age Estimation
- **Cellular interpretation exceeds source evidence** The Discussion acknowledges that plasma proteins may be produced or released more broadly, yet the conclusions retain cellular-resolution and therapeutic interpretations.
  - Dimension: positioning
  - Location: Discussion, limitations and conclusion

## Reliability checks

Caveats (3 of 4 checks).

- **Results check:** Noted. One reported value does not reconcile, but the key claims do not rest on it.
  - Minor reporting notes (1):
    - Descriptive: "Similarly, in the UKB, 26.1% showed no extreme cellular age gaps" (Results, cellular aging distributions) vs "Kaplan–Meier curves stratified by extreme aging burden: normal agers (n = 10,155, ~90% survival); 1–5 extreme cell types (n = 30,239, ~85%); 6–10 (n = 2,940, ~73%); 11–20 (n = 862, ~52%); 20+ (n = 262, ~34%)." (Figure 5d caption). The Figure 5d categories sum to 44,458 participants, and 10,155/44,458 × 100 = 22.84%, not 26.1%, although whether the two passages use identical normal-aging definitions is not specified. → Conclusion holds
- **Reporting and transparency:** Noted. The NSHD longitudinal mortality methods describe deaths as censoring, whereas the figure caption describes death as the event; the supplied text does not establish how the analysis actually encoded deaths.
  - Ethics approval: declared · Data availability: declared
- **Reference integrity:** Not checked. Reference integrity check could not run: references could not be reliably parsed from the manuscript; verification skipped rather than risk false verdicts.
  - 0 references in manuscript

## Post-publication record

- **Status:** Clean
- **Summary:** No retraction or expression of concern found in Crossref (includes Retraction Watch).
- **Last checked:** 2026-10-17
